NCT06468709
- Conditions
- Autoimmune Diseases, Autoimmune Pancreatitis, Chronic Disease, +10 more
- Locations
-
- Ruijin Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Pancreatitis, Chronic
Explore clinical trials studying Pancreatitis, Chronic. Study availability and eligibility vary by location and protocol.
11 public trials
1 recruiting study
Pancreatitis, Chronic trial results
Not Yet Recruiting
Validation of Joint-AI in Diagnosing Pancreatic Solid Lesions
NCT06753318
- Conditions
- Autoimmune Diseases, Autoimmune Pancreatitis, Chronic Disease, +17 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Completed
To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic Ultrasound
NCT04834505
- Conditions
- Autoimmune Diseases, Autoimmune Pancreatitis, Chronic Disease, +15 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT04397731
- Conditions
- Autoimmune Diseases, Autoimmune Pancreatitis, Chronic Disease, +8 more
- Locations
-
- Azienda Ospedaliera Integrata Verona Verona, Italy
- Tsukasa Ikeura Osaka, Japan
NCT06699667
- Conditions
- Autoimmune Diseases, Autoimmune Pancreatitis, Chronic Disease, +8 more
- Locations
-
Not specified
NCT05171517
- Conditions
- Adenoma, Adenoma, Islet Cell, Autoimmune Diseases, +21 more
- Locations
-
- Peking Union Medical College Hospital Beijing, China
NCT05565066
- Conditions
- Autoimmune Diseases, Autoimmune Pancreatitis, Chronic Disease, +20 more
- Locations
-
- Tongji Hospital, Tongji Medical College, HUST Wuhan, Hubei, China
NCT02705638
- Conditions
- Autoimmune Diseases, Autoimmune Pancreatitis, Chronic Disease, +14 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT03241797
- Conditions
- Autoimmune Diseases, Autoimmune Pancreatitis, Chronic Disease, +8 more
- Locations
-
- Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Completed
Rituximab in IgG4-RD: A Phase 1-2 Trial
NCT01584388
- Conditions
- Autoimmune Diseases, Autoimmune Pancreatitis, Chronic Disease, +24 more
- Locations
-
Not specified